In conclusion, we demonstrate here that by exploiting our novel screening platform it is possible to identify compounds like econazole, clotrimazole, fenticonazole, and tigecycline working as novel “anti-estrogens” preventing E2:ERα signaling to BC cell proliferation. The gene discussed is ESR1; the disease is breast cancer.